Key indicators: single-crystal X-ray study; T = 298 K; mean (C-C) = 0.011 Å; R factor = 0.076; wR factor = 0.236; data-to-parameter ratio = 11.0.
In the title compound, C 31 H 32 BrN 3 O 3 , the morpholine ring adopts a chair conformation, and the planar quinoline system is twisted with respect to the phenyl rings, with dihedral angles of 17.6 (4) and 75.1 (3) . Intramolecular C-HÁ Á ÁO and C-HÁ Á ÁN hydrogen bonds are present. The crystal packing is stabilized by weak C-HÁ Á ÁO hydrogen bonding and C-HÁ Á Á interactions.
Related literature
For the synthesis of other phamaceutically active derivatives through conventional and other synthetic routes, see: Andries et al. (2005) ; Gaurrand et al. (2006) ; Mao et al. (2007) ; Dalla Via et al. (2008) . For related structures, see: Petit et al. (2007) ; Rahmani et al. (2009) .
Experimental
Crystal data 
À3
Absolute structure: Flack (1983) , 1149 Friedel pairs Flack parameter: 0.14 (2) Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes: (i) x À 1; y; z; (ii) x; y; z þ 1; (iii) x þ 1; y; z. Cg4 and Cg5 are the centroids of the O3,C1,C2,N3,C3,C4 and C27-C32 rings, respectively.
Data collection: SMART (Bruker, 2001 ); cell refinement: SAINT (Bruker, 2001 ); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL. N- 
Comment
The quinolines and their derivatives as a class of extremely important heterocyclic compounds are used in a wide array of synthetic and medcinal applications. Some quinoline derivatives can give effective and good quality drugs treating many cancers (Dalla Via et al., 2008) , and also used as antifungals and antituberculostatics drugs (Andries et al., 2005; Mao et al., 2007; Gaurrand et al., 2006) . We report herein the crystal structure of the title compound.
In the molecule of the title compound (Fig 1) , the morpholine system exists in a chair conformation. The dihedral angles of aromatic rings are different from related structure TMC-207 (Petit et al., 2007; Rahmani et al., 2009) , which has been completed Phase II clinical, and will be marked in 2012 as a kind of antituberculostatics drug. The dihedral angle between phenyl ring [C9-C14] and substituted quinolinyl groups is 17.6 (4)°, the dihedral angle between phenyl ring [C27-C32] and substituted quinolinyl groups is 75.1 (3)°, and the dihedral angle between phenyl ring [C9-C14] and phenyl ring [C27-C32] is 68.3 (4)°; while the dihedral angles between phenyl and substituted quinolinyl groups in related structure TMC-207 is 97.4°, and naphthalenyl and substituted quinolinyl groups is nearly coplanar. The distance of the centroids between the phenyl ring [C9-C14] and the ring containing N of the substituted quinolinyl groups is 3.598 Å. The results suggest that the differences between them are caused by steric three-dimensional space. The structural cohesion of the title compound is ensured by weaker contacts. The C-H···O and C-H···N hydrogen bonding is present in the crystal structure (Table 1) .
Experimental
To a solution of N- ((6-bromo-2-methoxyquinolin-3-yl) phenylmethyl)-2-chloro-N-(1-phenylethyl)acetamide (1 mmol) and potassium carbonate (5 mmol) in acetonitrile (50 ml), morpholine (1 mmol) was added. The mixture was stirred for 6 h below 353 K. The reaction mixture was left for 2 h and then diluted with water (50 ml). The resulting precipitate was collected by extraction, distillation and purified on silica gel column (30% ethyl acetate in hexane) to give white powder (91.2% yield).
Crystals suitable for X-ray analysis were obtained from acetonitrile solution by slow evaporation.
Refinement
All H atoms were geometrically positioned (C-H 0.93-0.98 Å) and treated as riding, with U iso (H) = 1.5U eq (C) for methyl H atoms and 1.2U eq (C) for the others.
Figures Fig. 1 . The structure of the title compound with all non-H atom-labeling scheme and ellipsoids drawn at the 30% probability level.
supplementary materials sup-2 N-[(6-Bromo-2-methoxy-3-quinolyl)phenylmethyl]-2-morpholino-N-(1-phenylethyl)acetamide
Crystal data Hydrogen site location: inferred from neighbouring sites Least-squares matrix: full H-atom parameters constrained 
